Page last updated: 2024-08-23

paclitaxel and Neoplasm Metastasis, Unknown Primary

paclitaxel has been researched along with Neoplasm Metastasis, Unknown Primary in 53 studies

Research

Studies (53)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (11.32)	18.2507
2000's	27 (50.94)	29.6817
2010's	12 (22.64)	24.3611
2020's	8 (15.09)	2.80

Authors

Authors	Studies
Jin, LF; Shen, WZ; Zhang, M; Zhao, M	1
Nishio, K	1
Ding, J; Fan, H; Mei, J; Wang, H; Xu, J	1
Ikemura, M; Komura, A; Miyamoto, Y; Mori, M; Nishijima, A; Oda, K; Osuga, Y; Sone, K; Taguchi, A; Tanikawa, M	1
Hirabayashi, K; Ishida, R; Mizuno, M; Morioka, T; Niikura, N; Okamura, T; Sakaeda, S; Terao, M; Tsuda, B; Watanabe, T; Yokoyama, K	1
Bokemeyer, C; Folprecht, G; Grünwald, V; Hofheinz, RD; Huebner, G; Kasper, S; Köhne, CH; Krämer, A; Kretzschmar, A; Löffler, H; Schütte, K; Stahl, M; Stein, A; Trautmann, K	1
Chosokabe, M; Deura, I; Kawamoto, H; Koike, J; Kondo, H; Kuji, S; Maeda, I; Migita, O; Ohara, T; Suzuki, N; Tozawa-Ono, A; Tsugawa, K	1
Estrella, JS; Huey, RW; Matamoros, A; Overman, MJ; Raghav, KPS; Smaglo, BG; Varadhachary, GR	1
Akiyoshi, K; Arai, M; Fujita, Y; Hayashi, H; Koh, Y; Kurata, T; Matsubara, N; Matsumoto, K; Minami, H; Mukai, H; Nakagawa, K; Nishio, K; Ohashi, Y; Ono, A; Onoe, T; Onozawa, Y; Sakai, K; Takeda, K; Takeuchi, A; Takiguchi, Y; Toyoda, M	1
Hayashi, H; Nakagawa, K; Nishio, K	1
Conway, AM; Cook, N; Mitchell, C	1
Allouache, D; Büschenfelde, CM; Daugaard, G; Fizazi, KS; Greco, FA; Hainsworth, JD; Hübner, G; Knoblauch, P; Lesimple, T; Penel, N; Stahl, MJ	1
Bekaii-Saab, T; Kleiber, B; Lustberg, MB; Mikhail, S; Monk, P; Mortazavi, A; Ruppert, AS; Villalona-Calero, M	1
Erlichman, C; Foster, NR; Goetz, MP; Marchello, BT; Mattar, BI; Meyers, JP; Mowat, RB; Pillai, R; Prow, DM; Reynolds, CM; Steen, PD; Visscher, DW; Yoon, HH	1
Hirano, M; Nomura, Y; Shima, S; Tamura, H; Toriumi, T	1
Al-Batran, SE; Aldaoud, A; Bernhard, H; Burkart, C; Folprecht, G; Hoffmann, M; Huebner, G; Jahn, A; Kaiser, U; Kohne, CH; Kretzschmar, A; Kullmann, F; Link, H; Menges, M; Otremba, B; Schoffski, P; Stahl, M; Steinbach, S	1
Burges, A; Ditsch, N; Hillemanns, P; Kuemper, C; Lenhard, M; Mueller-Egloff, S; Strauss, A	1
Greco, FA; Hainsworth, JD; Lane, CM; Murphy, PB; Naot, Y; Spigel, DR; Thompson, DS; Waterhouse, DM	1
Hatake, K; Ishikawa, Y; Kodaira, M; Mishima, Y; Saotome, T; Takahashi, S; Takeuchi, K; Terui, Y; Ueda, K; Yamada, S; Yamamoto, N; Yokoyama, M	1
Daugaard, G; Gothelf, A; Møller, AK; Pedersen, KD	1
Chudy, B; Łata, S	1
Ando, M; Fujiwara, Y; Hirata, T; Katsumata, N; Ono, M; Shimizu, C; Tamura, K; Yamamoto, H; Yonemori, K	1
Endo, S; Endo, T; Hasegawa, T; Hironaka, M; Nakano, T; Nakayama, M; Sugiyama, Y	1
Krüger, I; Lindenfelser, R; Scherwitz, P	1
André, T; Culine, S; Epaud, C; Gligorov, J	1
Ando, M; Katsumata, N; Mukai, H; Watanabe, T	1
Barceló, R; Ferreiro, J; Fuente, N; López Vivanco, G; Muñoz, A; Rubio, I	1
Sawamura, D; Shimizu, S; Tsuchiya, K; Yasui, C; Yasukawa, K	1
Burris, HA; Erland, JB; Greco, FA; Hainsworth, JD; Hermann, R; Litchy, S; Morrissey, LH; Rodriguez, GI; Shaffer, DW; Yardley, DA	1
Choi, SJ; Kim, HT; Park, YH; Ryoo, BY; Yang, SH	1
El-Rayes, BF; Ferris, AM; Heilbrun, LK; Jain, V; Philip, PA; Shields, AF; Terry, D; Zalupski, M	1
Chin, K; Hatake, K; Inamura, K; Ito, Y; Kobayashi, T; Mishima, Y; Mizunuma, N; Nagasaki, E; Nishimori, H; Shinozaki, E; Takahashi, S; Terui, Y; Yokoyama, M	1
Conroy, M; Cree, IA; Fernando, A; Knight, LA; Kurbacher, CM; Polak, M	1
Dabbagh, L; Dumontet, C; Hanson, J; Johnson, L; Lai, R; Mackey, JR; Reiman, T; Santos, C; Sawyer, M; Sève, P	1
Gejyo, F; Kagamu, H; Suzuki, E; Tanaka, H; Tanaka, J; Tsuboi, K; Watanabe, S; Yoshizawa, H	1
Auerbach, JD; Baldwin, K; Chin, KR; Lackman, RD; Pandya, NK	1
Comella, G; Danova, M; Ferraú, F; Lorusso, V; Massidda, B; Nortilli, R; Palmeri, L; Palmeri, S; Porta, C; Vaglica, M	1
Chiba, N; Gamoh, M; Ishioka, C; Kakudo, Y; Kato, S; Murakawa, Y; Nishino, Y; Ohori, H; Ohtsuka, K; Sakayori, M; Shibata, H; Shimodaira, H; Suzuki, T; Takahashi, M; Takahashi, S; Yamaura, G; Yasuda, K; Yoshioka, T	1
Bower, JH; Muenter, MD	1
Erland, JB; Greco, FA; Hainsworth, JD; Kalman, LA; Schreeder, MT	1
Rowinsky, EK	1
Greco, FA; Hainsworth, JD	3
de Mulder, PH; de Wit, R; Louwerens, M; Rodenhuis, S; Schornagel, J; Verweij, J	1
Burris, HA; Erland, JB; Gray, J; Greco, FA; Hainsworth, JD; Hermann, RC; Morrissey, LH; Steis, R; Thompson, D	1
Bhupalam, L; Fleming, DR; Glisson, SD; Goldsmith, GH; LaRocca, RV; Michelson, GD	1
Bafaloukos, D; Briasoulis, E; Christodoulou, C; Fountzilas, G; Kalofonos, H; Kosmidis, P; Pavlidis, N; Samantas, E; Skarlos, D; Xiros, N	1
Burris, HA; Erland, JB; Gray, JR; Greco, FA; Hainsworth, JD; Kalman, LA; Schreeder, MT	1
Beijnen, JH; Jewell, RC; Koopman, FJ; Malingré, MM; Paul, EM; Rosing, H; Schellens, JH; Ten Bokkel Huinink, WW	1
Dowell, JE; Garrett, AM; Hande, KR; Johnson, DH; Shyr, Y	1
Daniele, B; de Bellis, M; Gridelli, C; Losito, S; Rossi, GB	1
Barton, JH; Bradof, JE; Burris, HA; Erland, JB; Greco, FA; Hainsworth, JD; Litchy, S; Morrissey, LH; Richards, P; Scullin, DC	1

Reviews

3 review(s) available for paclitaxel and Neoplasm Metastasis, Unknown Primary

Article	Year
A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site. Japanese journal of clinical oncology, 2004, Volume: 34, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasms, Unknown Primary; Neutropenia; Paclitaxel	2004
Paclitaxel pharmacology and other tumor types. Seminars in oncology, 1997, Volume: 24, Issue:6 Suppl 19 Topics: Alkylating Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Endometrial Neoplasms; Esophageal Neoplasms; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphoma; Male; Neoplasms; Neoplasms, Unknown Primary; Paclitaxel; Platinum Compounds; Sarcoma, Kaposi; Stomach Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine	1997
The evolving role of paclitaxel for patients with carcinoma of unknown primary site. Seminars in oncology, 1999, Volume: 26, Issue:1 Suppl 2 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Etoposide; Humans; Neoplasms, Unknown Primary; Paclitaxel	1999

Trials

24 trial(s) available for paclitaxel and Neoplasm Metastasis, Unknown Primary

Article	Year
[Genomic Analysis-Based Treatment for Cancer of Unknown Primary]. Gan to kagaku ryoho. Cancer & chemotherapy, 2022, Volume: 49, Issue:3 Topics: Carboplatin; Gene Expression Profiling; Genomics; Humans; Neoplasms, Unknown Primary; Paclitaxel	2022
Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP. British journal of cancer, 2021, Volume: 124, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Progression-Free Survival; Survival Rate	2021
Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 03-01, Volume: 37, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Carboplatin; Female; Gene Expression Profiling; Genetic Predisposition to Disease; Humans; Japan; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Patient Selection; Phenotype; Precision Medicine; Predictive Value of Tests; Progression-Free Survival; Prospective Studies; Time Factors; Transcriptome	2019
Paclitaxel/carboplatin with or without belinostat as empiric first-line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial. Cancer, 2015, May-15, Volume: 121, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Disease-Free Survival; Drug Administration Schedule; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Sulfonamides; Treatment Failure	2015
Biomodulation of capecitabine by paclitaxel and carboplatin in advanced solid tumors and adenocarcinoma of unknown primary. Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:5 Topics: Activation, Metabolic; Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Induction; Esophageal Neoplasms; Fatigue; Female; Gene Expression Regulation, Neoplastic; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Paclitaxel; Pancreatic Neoplasms; Prodrugs; Thymidine Phosphorylase; Treatment Outcome; Up-Regulation; Young Adult	2015
Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance). Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Everolimus; Female; Gene Expression Profiling; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Prospective Studies; Treatment Outcome	2016
Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial. British journal of cancer, 2009, Jan-13, Volume: 100, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; ErbB Receptors; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Proportional Hazards Models; Prospective Studies; Vinblastine; Vinorelbine	2009
Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site. The oncologist, 2009, Volume: 14, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Disease-Free Survival; Erlotinib Hydrochloride; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Quinazolines; Survival Rate; Young Adult	2009
Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study. Acta oncologica (Stockholm, Sweden), 2010, Volume: 49, Issue:4 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Risk Factors; Treatment Outcome	2010
[Prognostic and predictive factors of patients with cancer of unknown origin treated with a paclitaxel-based chemotherapy]. Medicina clinica, 2004, Feb-21, Volume: 122, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Predictive Value of Tests; Prognosis; Survival Rate	2004
Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial. The oncologist, 2004, Volume: 9, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Treatment Outcome	2004
A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site. Japanese journal of clinical oncology, 2004, Volume: 34, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasms, Unknown Primary; Neutropenia; Paclitaxel	2004
A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primary. American journal of clinical oncology, 2005, Volume: 28, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Survival Analysis	2005
Class III beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site. Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carboplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Multivariate Analysis; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Treatment Outcome; Tubulin	2007
Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : results of an Italian multicenter, randomized, phase II study. Cancer, 2006, Dec-15, Volume: 107, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Injections, Intravenous; Italy; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Vinblastine; Vinorelbine	2006
Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:6 Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Survival Analysis	1997
One-hour paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of carcinoma of unknown primary site. Seminars in oncology, 1997, Volume: 24, Issue:6 Suppl 19 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Survival Rate; Treatment Outcome	1997
Management of intermediate-prognosis germ-cell cancer: results of a phase I/II study of Taxol-BEP. International journal of cancer, 1999, Dec-10, Volume: 83, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Etoposide; Germinoma; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Testicular Neoplasms	1999
Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Infusions, Intravenous; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Statistics, Nonparametric; Survival Analysis; Taxoids; Treatment Outcome	2000
Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies. American journal of clinical oncology, 2000, Volume: 23, Issue:4 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Deoxycytidine; Diarrhea; Esophageal Neoplasms; Exanthema; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neoplasms, Unknown Primary; Neutropenia; Paclitaxel; Pancreatic Neoplasms; Paresthesia; Urinary Bladder Neoplasms; Vomiting	2000
Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:17 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Drug Administration Routes; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel	2000
Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients. British journal of cancer, 2001, Jan-05, Volume: 84, Issue:1 Topics: Acridines; Administration, Oral; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Humans; Infusions, Intravenous; Isoquinolines; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Tetrahydroisoquinolines	2001
A randomized Phase II trial in patients with carcinoma of an unknown primary site. Cancer, 2001, Feb-01, Volume: 91, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Treatment Outcome	2001
Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Mar-15, Volume: 20, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Survival Rate; Treatment Outcome	2002

Other Studies

27 other study(ies) available for paclitaxel and Neoplasm Metastasis, Unknown Primary

Article	Year
Successful treatment using immunotherapy in combination with chemotherapy for metastatic squamous cell carcinoma of unknown primary origin with bulky abdominal mass: A case report. Medicine, 2021, Dec-03, Volume: 100, Issue:48 Topics: Adult; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Duodenum; Female; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Neoplasms, Unknown Primary; Paclitaxel; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome	2021
Case Report: Successful Immunotherapy Improved the Prognosis of the Unfavorable Subset of Cancer of Unknown Primary. Frontiers in immunology, 2022, Volume: 13 Topics: Humans; Immunotherapy; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Positron Emission Tomography Computed Tomography; Prognosis	2022
A case of refractory pelvic squamous cell carcinoma of unknown primary that responded to nivolumab. The journal of obstetrics and gynaecology research, 2023, Volume: 49, Issue:4 Topics: Adult; Carboplatin; Carcinoma, Squamous Cell; Female; Humans; Neoplasms, Unknown Primary; Nivolumab; Paclitaxel; Papillomavirus Infections; Prognosis	2023
A Case of Unknown Primary Cancer with a Tumor Formed in the Retroperitoneum: A Case Report. The Tokai journal of experimental and clinical medicine, 2020, Jul-20, Volume: 45, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Fatal Outcome; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Positron-Emission Tomography; Retroperitoneal Neoplasms; Tomography, X-Ray Computed	2020
Value of adjuvant chemotherapy and informed microscopic examination for occult gynecologic cancer detected upon risk-reducing salpingo-oophorectomy after chemotherapy for BRCA1/2-associated breast cancer: a case report. Japanese journal of clinical oncology, 2021, Mar-03, Volume: 51, Issue:3 Topics: BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Fallopian Tube Neoplasms; Fallopian Tubes; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Paclitaxel; Salpingo-oophorectomy	2021
Cancer of Unknown Primary Presenting as Bone-Predominant or Lymph Node-Only Disease: A Clinicopathologic Portrait. The oncologist, 2021, Volume: 26, Issue:4 Topics: Humans; Kaplan-Meier Estimate; Lymph Nodes; Neoplasms, Unknown Primary; Paclitaxel; Prognosis	2021
Reply to A.-M. Conway et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 08-10, Volume: 37, Issue:23 Topics: Carboplatin; Gene Expression Profiling; Humans; Neoplasms, Unknown Primary; Paclitaxel	2019
Challenge of the Unknown: How Can We Improve Clinical Outcomes in Cancer of Unknown Primary? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 08-10, Volume: 37, Issue:23 Topics: Carboplatin; Gene Expression Profiling; Humans; Neoplasms, Unknown Primary; Paclitaxel	2019
[A Case of Axillary Nodal Metastasis of Adenocarcinoma of an Unknown Primary Site Effectively Treated with Anti-HER2plus AC plus Paclitaxel Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:10 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy, Needle; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasms, Unknown Primary; Paclitaxel; Trastuzumab	2016
Supraclavicular lymph node metastases of unknown origin: HPV-typing identifies the primary tumour. European journal of cancer care, 2009, Volume: 18, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Biopsy; Carcinoma, Squamous Cell; DNA, Viral; Female; Human papillomavirus 16; Humans; Incidental Findings; Lymphatic Metastasis; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Positron-Emission Tomography; Uterine Cervical Neoplasms	2009
Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma; Cohort Studies; Female; Health Status; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Retrospective Studies; Survival Analysis; Task Performance and Analysis	2010
[49 year old patient with staphylococcal sepsis caused by agranulocytosis after polychemotheraphy]. Przeglad lekarski, 2010, Volume: 67, Issue:5 Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Cisplatin; Female; Humans; Krukenberg Tumor; Middle Aged; Neoplasms, Unknown Primary; Ovarian Neoplasms; Paclitaxel; Sepsis; Staphylococcal Infections	2010
Second-line chemotherapy in patients with primary unknown cancer. Journal of cancer research and clinical oncology, 2011, Volume: 137, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Risk Factors; Taxoids; Time Factors; Treatment Failure; Treatment Outcome	2011
Multimodal treatment for multistation mediastinal lymph node adenocarcinoma: a case report. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2012, Volume: 18, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Chemotherapy, Adjuvant; Cisplatin; Humans; Immunohistochemistry; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasms, Unknown Primary; Paclitaxel; Positron-Emission Tomography; Recurrence; Reoperation; Thoracoscopy; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2012
[Localization of primary small cell carcinoma with liver metastasis: a rare combination of colonic adenocarcinoma and undifferentiated small cell carcinoma]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2002, Volume: 73, Issue:8 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Colectomy; Colon; Colonic Neoplasms; Docetaxel; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; Liver; Liver Neoplasms; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Paclitaxel; Taxoids; Time Factors; Vincristine	2002
[Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002) ]. Bulletin du cancer, 2002, Volume: 89 Spec No Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Enzyme Inhibitors; Female; Gemcitabine; Glutamates; Guanine; Humans; Immunotherapy; Lung Neoplasms; Mitomycins; Multicenter Studies as Topic; Neoplasms, Unknown Primary; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Pemetrexed; Radiotherapy; Remission Induction; Taxoids; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine; Vinorelbine	2002
Unknown primary carcinoma: a feasibility assessment of combination chemotherapy with cisplatin and docetaxel. International journal of clinical oncology, 2003, Volume: 8, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Diarrhea; Docetaxel; Drug Hypersensitivity; Feasibility Studies; Female; Humans; Male; Middle Aged; Nausea; Neoplasms, Unknown Primary; Neutropenia; Paclitaxel; Patient Compliance; Prospective Studies; Severity of Illness Index; Taxoids; Treatment Outcome; Vomiting	2003
Cutaneous adenocarcinoma metastases associated with swelling of the neck and cheeks. Acta dermato-venereologica, 2004, Volume: 84, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Cheek; Head and Neck Neoplasms; Humans; Male; Neck; Neoplasms, Unknown Primary; Paclitaxel; Skin Neoplasms	2004
[An autopsied case of metastatic endocrine carcinoma of the pancreas with primary site difficult to identify]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Docetaxel; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasms, Unknown Primary; Paclitaxel; Pancreatic Neoplasms; Taxoids	2005
Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay. Anti-cancer drugs, 2005, Volume: 16, Issue:9 Topics: Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Alendronate; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Caspase 3; Caspase 7; Caspases; Cell Line, Tumor; Cell Survival; Cisplatin; Clodronic Acid; Diphosphonates; Energy Metabolism; Female; Humans; Imidazoles; Inhibitory Concentration 50; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured; Zoledronic Acid	2005
[A case of squamous cell carcinoma of unknown primary site with involvement of cervico-mediastinal lymph nodes successfully treated by chemoradiotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Routes; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Neck; Neoplasms, Unknown Primary; Paclitaxel	2006
Spinal cord compression in a patient with multiple hereditary exostoses caused by breast adenocarcinoma metastatic to osteochondromas of the spine: case report. Spine, 2006, Nov-15, Volume: 31, Issue:24 Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chondrosarcoma; Combined Modality Therapy; Decompression, Surgical; Diagnosis, Differential; Exostoses, Multiple Hereditary; Female; Humans; Laminectomy; Liver Neoplasms; Lung Neoplasms; Neoplasms, Unknown Primary; Paclitaxel; Spinal Cord Compression; Spinal Fusion; Spinal Neoplasms; Thoracic Vertebrae; Tomography, X-Ray Computed; Trastuzumab	2006
[Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Survival Rate	2007
Temporary worsening of parkinsonism in a patient with Parkinson's disease after treatment with paclitaxel for a metastatic grade IV adenocarcinoma. Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Female; Humans; Infusions, Intravenous; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Unknown Primary; Paclitaxel; Parkinson Disease	1995
Management of patients with cancer of unknown primary site. Oncology (Williston Park, N.Y.), 2000, Volume: 14, Issue:4 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Carcinoma; Etoposide; Evaluation Studies as Topic; Female; Humans; Male; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Survival Rate; Taxoids	2000
Carcinoma of unknown primary site. Cancer, 2000, Dec-15, Volume: 89, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase II as Topic; Etoposide; Fatigue; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasms, Unknown Primary; Paclitaxel; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vomiting	2000
Ischemic colitis associated with paclitaxel. Journal of clinical gastroenterology, 2001, Volume: 33, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Colitis, Ischemic; Diagnosis, Differential; Female; Humans; Intestinal Mucosa; Liver Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Paclitaxel; Sigmoidoscopy	2001